Predictions
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€55.70
19.07.23
19.07.23
€52.70
19.07.24
19.07.24
-30.39%
05.07.24
05.07.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€76.16
13.07.23
13.07.23
€113.58
13.07.24
13.07.24
-1.84%
03.07.24
03.07.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€76.16
13.07.23
13.07.23
€125.20
13.07.24
13.07.24
-1.84%
03.07.24
03.07.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€85.44
24.06.23
24.06.23
€100.00
31.07.25
31.07.25
-12.20%
03.07.24
03.07.24
Could be very worthwhile Investment >20% year
AstraZeneca plc
Start price
Target price
Perf. (%)
€124.30
11.11.22
11.11.22
€165.00
08.09.26
08.09.26
19.22%
05.07.24
05.07.24
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
positive Cash Flow expected
AstraZeneca plc
Start price
Target price
Perf. (%)
€124.30
11.11.22
11.11.22
€165.00
08.09.26
08.09.26
19.22%
05.07.24
05.07.24
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
positive Cash Flow expected
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€196.52
08.01.22
08.01.22
€915.00
14.01.27
14.01.27
122.75%
05.07.24
05.07.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
ROE higher than 15% per year
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€196.52
08.01.22
08.01.22
€915.00
14.01.27
14.01.27
122.75%
05.07.24
05.07.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
ROE higher than 15% per year
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€196.52
08.01.22
08.01.22
€915.00
14.01.27
14.01.27
122.75%
05.07.24
05.07.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
ROE higher than 15% per year
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€70.48
30.09.16
30.09.16
€98.00
08.09.26
08.09.26
12.54%
05.07.24
05.07.24
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€70.48
30.09.16
30.09.16
€98.00
08.09.26
08.09.26
12.54%
05.07.24
05.07.24
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€70.48
30.09.16
30.09.16
€98.00
08.09.26
08.09.26
12.54%
05.07.24
05.07.24
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued